Literature DB >> 32624279

Inferior Cancer Survival for Men with Localized High-grade Prostate Cancer but Low Prostate-specific Antigen.

Christian D Fankhauser1, Kathryn L Penney2, Amparo G Gonzalez-Feliciano3, Noel W Clarke4, Thomas Hermanns5, Konrad H Stopsack6, Michelangelo Fiorentino7, Massimo Loda8, Brandon Mahal9, Travis A Gerke10, Mark A Preston11, Lorelei A Mucci3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32624279      PMCID: PMC8411278          DOI: 10.1016/j.eururo.2020.05.035

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  3 in total

1.  Biology and evolution of poorly differentiated neuroendocrine tumors.

Authors:  David S Rickman; Himisha Beltran; Francesca Demichelis; Mark A Rubin
Journal:  Nat Med       Date:  2017-06-06       Impact factor: 53.440

2.  Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3?

Authors:  Jennifer R Stark; Sven Perner; Meir J Stampfer; Jennifer A Sinnott; Stephen Finn; Anna S Eisenstein; Jing Ma; Michelangelo Fiorentino; Tobias Kurth; Massimo Loda; Edward L Giovannucci; Mark A Rubin; Lorelei A Mucci
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

3.  Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.

Authors:  Brandon A Mahal; David D Yang; Natalie Q Wang; Mohammed Alshalalfa; Elai Davicioni; Voleak Choeurng; Edward M Schaeffer; Ashley E Ross; Daniel E Spratt; Robert B Den; Neil E Martin; Kent W Mouw; Peter F Orio; Toni K Choueiri; Mary-Ellen Taplin; Quoc-Dien Trinh; Felix Y Feng; Paul L Nguyen
Journal:  Eur Urol       Date:  2018-02-22       Impact factor: 20.096

  3 in total
  2 in total

1.  Single-cell proteomics defines the cellular heterogeneity of localized prostate cancer.

Authors:  Laura De Vargas Roditi; Andrea Jacobs; Jan H Rueschoff; Pete Bankhead; Stéphane Chevrier; Hartland W Jackson; Thomas Hermanns; Christian D Fankhauser; Cedric Poyet; Felix Chun; Niels J Rupp; Alexandra Tschaebunin; Bernd Bodenmiller; Peter J Wild
Journal:  Cell Rep Med       Date:  2022-04-19

2.  Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial.

Authors:  Anthony V D'Amico; Wanling Xie; Elizabeth McMahon; Marian Loffredo; Shana Medeiros; David Joseph; Jim Denham; Parvesh Kumar; Glenn Bubley; Molly Sullivan; Richard Hellwig; Juan Carlos Vera; Rolf Freter; W Jeffrey Baker; Jeffrey Y Wong; Andrew A Renshaw; Philip W Kantoff
Journal:  J Clin Oncol       Date:  2021-07-01       Impact factor: 50.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.